share_log

HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

HC Wainwright & Co.維持對Panbela Therapeutics的買入,將目標股價下調至5美元
Moomoo 24/7 ·  04/02 08:49

HC Wainwright & Co. analyst Joseph Pantginis maintains Panbela Therapeutics (OTC:PBLA) with a Buy and lowers the price target from $16 to $5.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯維持Panbela Therapeutics(場外交易代碼:PBLA)的買入並將目標股價從16美元下調至5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論